Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.89NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
M.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.333NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.429NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.463NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
U.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.373NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.80NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.433NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.242NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.449NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.152NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.146NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.71NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.445NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.237NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBNNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.462NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.147NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.6 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.5 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.4 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.420NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.39.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.233NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.635NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.19 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used